Raquel Maia is a Post-Doc Researcher responsible for the development of a 3D Multi-Tissue In vitro Tumor-Model-on-a-Chip. Her duties at 3B’s include performing research activities related to this and to other projects that she is involved. She actively contributes to the preparation/submission of R&D project applications in different funding agencies at national and international level.
Raquel Maia has been working at 3B’s Research Group since 2014 on the field of Cancer 3D in vitro models, namely for investigation of the metastasis process and for drug development with the intent to produce efficient patient-specific therapies. She has experience in the development of hydrogels/scaffolds based on several biomaterials, such as alginate and RADA-16I. Her research interests are also focused to exploit new approaches to direct stem cells differentiation, namely osteoblasts differentiation.
Since 2008, she has been working as a team member in national funded projects (i.e. NanoCues and BIOMATRIX) that address tissue engineering and regenerative medicine applications especially for bone regeneration. She is currently developing pathophysiological relevant in vitro models for cancer research, allowing real-time visualization of cell-cell and cell-extracellular matrix interactions as well as with a vascular interface mimicked by microfluidic approaches. As a result of her research efforts she is currently author of 4 publications and co-author of 4 publications. Additionally, she has presented several communications (oral and posters) in International Conferences on the fields of Biomaterials and Regenerative Medicine, has received 2 scientific awards and has been acting as referee of several international peer-reviewed journals upon invitation.
She has an ISI h-index of 5 and received ~78 citations.
Back to top